latest news on glp 1 drugs Risks of Ozempic, other GLP-1 are at center of sweeping lawsuit that kicked off in Philadelphia What to know about the

In a statement posted on its website on Tuesday (02/24), Sciwind called the deal "an important first step to advance Pfizer's global strategy in the metabolic field in China." Ecnoglutide itself already got the green light from Chinese regulators back in January 2026 for treating type 2 diabetes

MASH typically develops in individuals with obesity, insulin resistance, and metabolic syndrome

Although GLP-1RAs have shown remarkable efficacy in weight management, several barriers limit their full integration into mainstream obesity care

Thats usually a conversation patients have with their doctors, who know a lot about these medications and how they work. Microdosing compounded versions of GLP-1s is different from having a doctor adjust the prescribed dosage of your GLP-1 medication